natgillin/translations-raw huggingface dataset:
3 http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/referrals/Hipralona_Enro 
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/veterinary/referrals/Hipralona_EnroS/vet_referral_000067.jsp&mid=WC0b01ac05805c5170
Based on the available data in sheep and with the addition of an uncertainty factor of 1.5 a goat meat and offal withdrawal period of 6 days is supported following a subcutaneous injection at the recommended dose of 5 mg/kg bw. 
Na podlagi razpoložljivih podatkov za ovce in ob upoštevanju faktorja negotovosti 1,5 je bila določena 6-dnevna karenca za kozje meso in organe po subkutanem injiciranju pri priporočenem odmerku 5 mg/kg telesne mase.
Several proprietary studies and numerous scientific publications, documenting the efficacy of enrofloxacin, either by injectable and/or oral route of administration, were provided to demonstrate the efficacy against the above specified bacteria for the intended indications in both dogs and cats 
Za dokazovanje učinkovitosti proti zgoraj navedenim bakterijam pri predvidenih indikacijah za pse in mačke se je predložilo več lastniških študij in veliko znanstvenih publikacij, ki so dokumentirale učinkovitost injiciranega in/ali peroralnega enrofloksacina.
Do not use this veterinary medicinal product after the expiry date which is stated on the vial after {abbreviation used for expiry date}. 
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na ovojnini .
Special caution should be taken when using enrofloxacin in animals with impaired renal function. 
Posebna previdnost je potrebna pri živalih z oslabljeno ledvično funkcijo.
Dogs, cats and other exotic species (rodents, rabbits, cage birds and reptiles (snakes, turtles and iguana)) 
Psi, mačke in ostale eksotične vrste (glodavci, kunci, ptice v kletkah in plazilci (kače, želve in iguane)
- In a study 4.2% of 71 isolates of Staph. 
- V nemški študiji, v kateri so med letoma 2006 in 2007 zbrali 71 izolatov Staph.
In cattle, sheep and goat, overdose has not been documented. 
Pri govedu, ovcah in kozah ni bila dokumentirana aplikacija prevelikega odmerka.
The use should be done only accordingly to the benefit-risk assessment by the responsible veterinarian. 
Uporabljati se sme samo v skladu z oceno razmerja med tveganji in koristmi, ki jo opravi odgovorni veterinar.
Bayer Portugal S.A. Rua Quinta do Pinheiro, 5 2794-003 Carnaxide Portugal 
Portugalska Bayer Portugal S.A. Rua Quinta do Pinheiro, 5
Cats have been shown to suffer ocular damage after receiving doses of more than 15 mg/kg once daily for 21 consecutive days. 
Pri mačkah so se pojavile poškodbe oči, pri odmerkih večjih od 15 mg/kg enkrat dnevno, 21 zaporednih dni.
Do not use this veterinary medicinal product after the expiry date which is stated on the vial after {abbreviation used for expiry date} 
Zdravila ne smete uporabljati po datumu izteka roka uporabnosti, navedenega na ovojnini.
The warning regarding possible degenerative changes of articular cartilage in calves is supported by a study in which calves (2 weeks old) were orally administered with 0, 30 or 90 mg/kg bw of enrofloxacin per day for 14 days. 
Opozorilo glede morebitnih degenerativnih sprememb sklepnega hrustanca pri teletih podpira študija, v kateri so teletom (starim 2 tedna) 14 dni dajali peroralni enrofloksacin v odmerku 0, 30 ali 90 mg/kg telesne mase na dan. Primarne degenerativne lezije so opazili v kolenskih sklepih vseh telet, ki so jih zdravili z odmerkom 90 mg/kg telesne mase, in enega teleta, zdravljenega z odmerkom 30 mg/kg telesne mase.
Treatment of infections of the alimentary and respiratory tracts where clinical experience, if possible supported by sensitive testing of the causal organism, indicates enrofloxacin as the substance of choice. 
Zdravljenje okužb prebavil in dihal, kadar klinične izkušnje, po možnosti podprte s preskusi občutljivosti povzročiteljev, kažejo, da je enrofloksacin priporočena učinkovina.
In dogs, cattle, sheep and goats, overdose has not been documented. 
Pri psih, govedu, ovcah in kozah ni bila dokumentirana aplikacija prevelikega odmerka.
are sparse. 
so redki.
Goat meat and offal (50 mg/ml and 100 mg/ml strengths) No residue depletion data were made available. 
Kozje meso in organi (jakosti 50 mg/ml in 100 mg/ml) Podatki o izločanju ostankov niso na voljo.
Enrofloxacin is active against many Gram-negative bacteria such as Escherichia coli, Klebsiella spp., Actinobacillus pleuropneumoniae, Mannheimia haemolytica, Pasteurella spp. 
Enroflokacin je v priporočenem terapevtskem odmerku zelo učinkovit proti številnim Gram-negativim bakterijam kot so Escherichia coli, Klebsiella spp, Actinobacillus pleuropneumoniae, Mannheimia haemolytica, Pasteurella spp.
Pigs (25 mg/ml, 50 mg/ml and 100 mg/ml strengths) Residue depletion data were made available and supported a pig meat and offal withdrawal period of 13 days following an intramuscular administration at the recommended dose of 5 mg/kg bw. 
Prašiči (jakosti 25 mg/ml, 50 mg/ml in 100 mg/ml) Podatki o izločanju ostankov so bili na voljo in so podpirali 13-dnevno karenco za svinjsko meso in organe po intramuskularni uporabi pri priporočenem odmerku 5 mg/kg telesne mase.
Clear light-yellow solution. 
Bistra, svetlo rumena raztopina
IV: Meat and offal: 5 days. 
Govedo: meso in organi iv. 5 dni sc. 10 dni
QUALITATIVE AND QUANTITATIVE COMPOSITION One ml solution contains: 
KAKOVOSTNA IN KOLIČINSKA SESTAVA
Shelf life after the first opening of the immediate packaging: 28 days. 
Rok uporabnosti po prvem odpiranju stične ovojnine: 28 dni.
5.1 Pharmacodynamic properties 
5.1 Farmakodinamične lastnosti Način delovanja
Enrofloxacin is active against many Gram-negative bacteria such as Escherichia coli, Klebsiella spp., Actinobacillus pleuropneumoniae, Pasteurella spp. 
Enroflokacin je v priporočenem terapevtskem odmerku zelo učinkovit proti številnim Gram-negativim bakterijam kot so Escherichia coli, Klebsiella spp, Actinobacillus pleuropneumoniae, Pasteurella spp.
Pigs, cattle 
Prašiči, govedo
At 50 mg/kg given once daily for 21 consecutive days, blindness can occur. 
Pri odmerku 50 mg/kg dajanemu enkrat dnevno, 21 zaporednih dni lahko nastopi slepota.
The product can be used in sows during lactation. 
Lahko se uporablja pri svinjah v obdobju laktacije.
EXPIRY DATE EXP {month/year} Once broached use by … 
DATUM IZTEKA ROKA UPORABNOSTI ZDRAVILA <EXP {mesec/leto}>
Digestive tract disorders (e.g. diarrhoea) may occur in very rare cases. 
Pri zdravljenju se lahko v zelo redkih primerih pojavijo prebavne motnje (npr. driska).
Do not refrigerate or freeze. 
Zdravilo ne shranjujte v hladilniku ali zamrzovalniku.
Dogs and cats: 5 mg of enrofloxacin/kg bw once daily by subcutaneous injection for up to 5 days. 
Psi in mačke: 5 mg enrofloksacina/kg telesne mase enkrat na dan s subkutanim injiciranjem do 5 dni.
Sheep and goats: 5 mg of enrofloxacin/kg bw once daily by subcutaneous injection for 3 days. 
Ovce in koze: 5 mg enrofloksacina/kg telesne mase enkrat na dan s subkutanim injiciranjem 3 dni.
In this case, the withdrawal period following subcutaneous injection applies. 
V tem primeru se upošteva karenco za subkutano aplikacijo.
Accumulation in plasma does not occur following a treatment interval of 24 h. In milk, most of drug activity consists on ciprofloxacin. 
V mleku, večina aktivnosti zdravila temelji na ciprofloksacinu.
SPECIAL STORAGE CONDITIONS Do not refrigerate or freeze. 
POSEBNA NAVODILA ZA SHRANJEVANJE Ne hranite v hladilniku ali zamrzovalniku.
Bayer Health Care AG D-51368 Leverkusen Germany 
Romunija Bayer Health Care AG D-51368 Leverkusen Nemčija
Taking into account the available data, the CVMP concluded that the poor bacteriological results obtained in vivo and the results from the PK/PD analysis do not sufficiently support this indication. 
Hudi akutni mastitis, ki ga povzroča Staphylococcus aureus (jakost 100 mg/ml) Upoštevajoč razpoložljive podatke je odbor CVMP sklenil, da slabi bakteriološki rezultati, pridobljeni in vivo, in rezultati iz FK/FD analize niso zadostni za podporo te indikacije.
the CVMP has recommended variations of the marketing authorisations for Baytril 2.5% injectable, Baytril 5% injectable and Baytril 10% injectable and their associated names as referred in Annex I for which the summaries of the product characteristics, labelling and package leaflets are set out in Annex III. 
• CVMP je pregledal povzetke glavnih značilnosti zdravila, označevanje in navodila za uporabo, ki jih predlagajo imetniki dovoljenj za promet, in upošteval vse predložene podatke; je odbor CVMP je priporočil spremembe dovoljenj za promet z zdravili Baytril 2,5 % za raztopina injiciranje, Baytril 5 % raztopina za injiciranje ter Baytril 10 % raztopina za injiciranje in povezanimi imeni, ki so navedena v Prilogi I in katerih povzetki glavnih značilnosti zdravila, označevanje in navodila za uporabo so na voljo v Prilogi III.
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis in cattle less than 2 years old. 
Zdravljenje akutnega artritisa, ki ga povzročaj na enrofloksacin občutljivi sevi Mycoplasmae bovis, pri govedu do drugega leta starosti.
Dogs, cats and exotic animals (small mammals, reptiles and avian species) 
Psi, mačke and eksotične živali (mali sesalci, plazilci in vrste ptic)
The safety of the veterinary medicinal product has not been established during pregnancy and lactation. 
Varnost zdravila ni bila ugotovljena med brejostjo in laktacijo.
Ornamental birds: 20 mg of enrofloxacin/kg bw once daily by intramuscular injection for 5-10 days. 
Okrasne ptice: 20 mg enrofloksacina/kg telesne mase enkrat na dan z intramuskularnim injiciranjem 5-10 dni.
Cattle, sheep, goats and pigs. 
Govedo, ovce, koze in prašiči.
Pigs, rabbit, dogs, cats, exotic animals (mammals, birds, reptiles) 
Prašiči, kunci, psi, mačke, eksotične živali (sesalci, ptiči, plazilci)
The safety of the veterinary medicinal product has not been established during lay. 
Varnost zdravila ni bila ugotovljena med brejostjo.
In other species, the safety of the veterinary medicinal product has not been established during pregnancy and lactation. 
Varnost zdravila za uporabo v veterinarski medicini v obdobju brejosti in laktacije pri drugih živalskih vrstah ni bila ugotovljena.
Bayer Animal Health GmbH D-51368 Leverkusen Germany 
Bayer Animal Health GmbH D-51368 Leverkusen Nemčija
- Dosage for ornamental birds: 20 mg/kg bw, once daily by intramuscular injection for 5-10 consecutive days. 
- Odmerjanje za okrasne ptice: 20 mg/kg telesne mase, enkrat na dan z intramuskularnim injiciranjem od 5 do 10 zaporednih dni.
For cats weighting less than 5 kg, the dosage of 25 mg/ml is more appropriate to avoid risk of overdosage (see Overdose). 
Za mačke, lažje od 5 kg, je bolj primeren odmerek
Doses of 30 mg/kg given once daily for 21 consecutive days have been shown to cause irreversible ocular damage. 
Odmerki 30 mg/kg dajani enkrat dnevno , 21 zaporednih dni so povzročili nepovratne poškodbe oči.
Dogs, cattle, pigs 
Psi, govedo, prašiči
MANUFACTURER'S BATCH NUMBER Batch {number} 
IZDELOVALČEVA ŠTEVILKA SERIJE Izpolni država članica
People with known hypersensitivity to fluoroquinolones should avoid any contact with the product. 
Posebni previdnostni ukrepi, ki jih mora izvajati oseba, ki živalim daje zdravilo Osebe z znano preobčutljivostjo na fluorokinolone naj se izogibajo stiku z zdravilom za uporabo v veterinarski medicini.
6.5 Nature and composition of immediate packaging Brown glass (type I) vials with a chlorobutyl polytetrafluoroethylene (PTFE) stopper and with a flipoff cap with aluminium case and plastic flip-off button. 
Rjava steklenice (tipa I) s klorobutilnim PTFE zamaškom, z zaporko iz aluminija in plastičnim snemljivim gumbom.
Do not use in the case of known hypersensitivity to fluoroquinolones or to any of the excipients. 
Ne uporabite v primeru preobčutljivosti na zdravilno učinkovino ali katerokoli pomožno snov.
Enrofloxacin and ciprofloxacin distribute well into all target tissues, e.g. lung, kidney, skin and liver, reaching 2- to 3-fold higher concentrations than in plasma. 
Enrofloksacin in ciprofloksacin se dobro porazdelita tudi na vsa ciljna tkiva, na primer pljuč, ledvic,
Two enzymes essential in DNA replication and transcription, DNA gyrase and topoisomerase IV, have been identified as the molecular targets of fluoroquinolones. 
Za ciljno delovanje flourokinolonov sta dva pomembna encima: DNK giraza in topoizomeraza IV, ki sodelujeta pri podvojevanju in prepisu DNK v bakterijski celici.Ciljna inhibicija nastane zaradi nekonvalentne vezave molekul fluorokinolonov na ta encima.
Sheep meat and offal (50 mg/ml and 100 mg/ml strengths) Residue depletion data were made available and supported a sheep meat and offal withdrawal period of 4 days following a subcutaneous injection at the recommended dose of 5 mg/kg bw. 
Ovčje meso in organi (jakosti 50 mg/ml in 100 mg/ml) Podatki o izločanju ostankov so bili na voljo in so podpirali 4-dnevno karenco za ovčje meso in organe po subkutanem injiciranju pri priporočenem odmerku 5 mg/kg telesne mase.
Dogs, cats, exotic animals (small mammals, reptiles and avian species) 
Psi, mačke, eksotične živali (mali sesalci, plazilci in vrste ptic)
Disposal: read package leaflet. 
Preberite navodilo za uporabo.
Rabbits and rodents: 10 mg of enrofloxacin/kg bw once daily by subcutaneous injection for 5-10 days. 
Kunci in glodavci: 10 mg enrofloksacina/kg telesne mase enkrat na dan s subkutanim injiciranjem 5-10 dni.
Acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis: 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily for 5 days. 
Zdravljenje akutnega atrtitisa, ki ga povzroča na enrofloksacin občutljiv sev Mycoplasma bovis: 5 mg enrofloksacina na kg telesne mase kar ustreza 1ml/10 kg t.t., enkrat dnevno, 5 dni.
Denmark Bayer Animal Health GmbH D-51368 Leverkusen 
Norveška Bayer Animal Health GmbH D-51368 Leverkusen
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) One ml solution contains 100 mg enrofloxacin and 30 mg n-butyl alcohol as preservative. 
1 ml raztopine za injiciranje vsebuje: 100 mg enrofloksacina in 30 mg n-butil alkohola kot pomožne snovi
Pharmacotherapeutic group: Antibacterials for systemic use, fluoroquinolones. 
Farmakoterapevtska skupina: antibiotiki za sistemsko uporabo, fluorokinoloni Oznaka ATC vet: QJ01MA90
Treatment of acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis 
Zdravljenje akutnega artritisa, ki ga povzročajo na enrofloksacin občutljivi sevi Mycoplasmae bovis,
Cats, dogs, sheep, cattle, pigs, goats 
Mačke, psi, ovce, govedo, prašiči, koze
Dogs, cats, cattle poultry, pigs 
Psi, mačke, govedo perutnina, prašiči
Reptiles: 5-10 mg of enrofloxacin/kg bw once daily by intramuscular injection for 5 days. 
Plazilci: 5-10 mg enrofloksacina/kg telesne mase enkrat na dan z intramuskularnim injiciranjem 5 dni.
5-10 mg/kg bw, corresponding to 0.2-0.4 ml/kg bw, once daily by intramuscular injection for 5 consecutive days. 
5-10 mg / kg telesne mase , kar ustreza 0,2-0,4 ml / kg telesne mase , enkrat dnevno, intramuskularno, 5 zaporednih dni.
Cattle meat and offal (50 mg/ml and 100 mg/ml strengths) Residue depletion data were made available and supported a cattle meat and offal withdrawal period of 5 days following an intravenous injection at the recommended dose of 5 mg/kg bw. 
Goveje meso in organi (jakosti 50 mg/ml in 100 mg/ml) Podatki o izločanju ostankov so bili na voljo in so podpirali 5-dnevno karenco za goveje meso in organe po intravenskem injiciranju pri priporočenem odmerku 5 mg/kg telesne mase.
20 mg/kg bw, corresponding to 0.8 ml/kg bw, once daily by intramuscular injection for 5 to 10 consecutive days. 
20 mg / kg telesne mase , kar ustreza 0,8 ml / kg telesne mase , enkrat na dan, intramuskularno, 5 do dni zapored .
10 mg/kg bw, corresponding to 2 ml/5 kg bw, once daily by subcutaneous injection for 5 to 10 consecutive days. 
Kunci 10 mg/kg t.t., kar ustreza 2 ml/ 5kg t.t enkrat dnevno, subkutano, od 5 do 10 zaporednih dni.
Cattle milk (100 mg/ml strength) 
Kravje mleko (jakost 100 mg/ml)
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION Intravenous, subcutaneous or intramuscular use. 
4.9 Odmerjanje in pot uporabe Uporablja se intravenozno, subkutano ali intramuskularno.
6.1 List of excipients n-Butyl alcohol 
Seznam pomožnih snovi n-butil alkohol kalijev hidroksid voda za injekcije
Dogs, cats, pigs (piglets), rabbits, rodents, reptiles and ornamental birds. 
Psi, mačke, prašiči (pujski), kunci, glodavci, plazilci, okrasne ptice.
Sheep, cattle, pigs, goats 
Ovce, govedo, prašiči, koze
Rodents, reptiles and ornamental birds 
Glodavci, plazilci, okrasne ptice
Cattle (calves), sheep, goats, pigs, dogs and cats. 
Govedo (teleta), ovce, koze, prašiči, psi in mačke.
NAME OF THE VETERINARY MEDICINAL PRODUCT <Invented name> 100 mg/ml solution for injection 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI <Izmišljeno ime> 100 mg/ml raztopina za injiciranje
To be completed nationally Manufacturer responsible for batch release: To be completed nationally 
SPROSTITEV SERIJE V EGP, ČE STA RAZLIČNA Izpolni država članica
The product can be administered by slow intravenous or subcutaneous administration. 
Zdravilo dajemo počasi intravenozno ali subkutano.
Calves, pigs, poultry, dogs, cats 
Teleta, prašiči, perutnina, psi, mačke
10 mg/kg bw, corresponding to 0.4 ml/kg bw, once daily by subcutaneous injection for 5 to 10 consecutive days. 
Glodavci 10 mg/kg t.t., kar ustreza 0,4 ml/ kg t.t enkrat dnevno, subkutano, od 5 do 10 zaporednih dni.
Acute mycoplasma-associated arthritis due to enrofloxacin susceptible strains of Mycoplasma bovis in cattle less than 2 years old: 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily for 5 days. 
Zdravljenje akutnega atrtitisa, ki ga povzroča Mycoplasma bovis pri govedu do drugega leta starosti: 5 mg enrofloksacina na kg telesne mase, kar ustreza 1ml/20 kg t.t., enkrat dnevno, 5 dni.
METHOD AND ROUTE(S) OF ADMINISTRATION SC, IM 
NAČIN IN POT(I) UPORABE
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) One ml solution contains 25 mg enrofloxacin and 30 mg n-butyl alcohol as preservative. 
1 ml raztopine za injiciranje vsebuje: 25 mg enrofloksacina in 30 mg n-butil alkohola kot pomožne snovi
Dogs, pigs, cattle, cats 
Psi, prašiči, govedo, mačke
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) One ml solution contains 50 mg enrofloxacin and 30 mg n-butyl alcohol as preservative. 
1 ml raztopine za injiciranje vsebuje: 50 mg enrofloksacina in 30 mg n-butil alkohola kot pomožne snovi
Cattle, pigs, sheep, goats 
Govedo, prašiči, ovce, koze
Sheep and Goats (50 mg/ml and 100 mg/ml strengths) 
Ovce in koze (jakosti 50 mg/ml in 100 mg/ml)
NAME OF THE VETERINARY MEDICINAL PRODUCT <Invented name> 25 mg/ml solution for injection Enrofloxacin 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI <Izmišljeno ime> 25 mg/ml, raztopina za injiciranje enrofloksacin
- Dosage for rodents: 10 mg/kg bw, once daily by subcutaneous injection for 5-10 consecutive days 
- Odmerjanje za glodavce: 10 mg/kg telesne mase, enkrat na dan s subkutanim injiciranjem od 5 do 10 zaporednih dni.
AUC (µg∙h/ml) 
Odmerek (mg/kg tt)
NAME OF THE VETERINARY MEDICINAL PRODUCT <Invented name> 25 mg/ml solution for injection 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI <Izmišljeno ime> 25 mg/ml raztopina za injiciranje
2.5 mg of enrofloxacin/kg bw, corresponding to 0.5 ml/20 kg bw, once daily by intramuscular injection for 3 days. 
2,5 mg enrofloksacina na kilogram telesne mase, kar ustreza 0.5 ml/ 20kg t.t, enkrat dnevno,3 dni, intramuskularno.
Alimentary tract infection or septicaemia caused by Escherichia coli: 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/10 kg bw, once daily by intramuscular injection for 3 days. 
Okužbe prebavil ali septikemija,ki jo povzroča Escherichia coli: 5 mg enrofloksacina na kg telesne mase, kar ustreza 1ml/10 kg t.t., enkrat dnevno, 3 dni, intramuskularno.
and Actinobacillus pleuropneumoniae. 
Staphylococcus aureusa.
NAME OF THE VETERINARY MEDICINAL PRODUCT <Invented name> 50 mg/ml solution for injection Enrofloxacin 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI <Izmišljeno ime> 50 mg/ml, raztopina za injiciranje enrofloksacin
Cattle, pigs, dogs 
Govedo, prašiči, psi
Alimentary tract infection, or septicaemia caused by Escherichia coli: 5 mg of enrofloxacin/kg bw, corresponding to 1 ml/20 kg bw, once daily by intramuscular injection for 3 days. 
Okužbe prebavil ali septikemija,ki jo povzroča Escherichia coli: 5 mg enrofloksacina na kg telesne mase kar ustreza 1ml/20 kg t.t., enkrat dnevno, 3 dni, intramuskularno.
Cattle, pigs, dogs, cats 
Govedo, prašiči, psi, mačke
Sheep milk (50 mg/ml and 100 mg/ml strengths) 
Ovčje mleko (jakosti 50 mg/ml in 100 mg/ml)
Treatment of acute severe mastitis caused by enrofloxacin susceptible strains of Escherichia coli. 
Zdravljenje akutnega mastitisa, ki ga povzročajo na enrofloksacin občutljivi sevi Escherichiae coli.
Cattle (calves), pigs, dogs 
Govedo (teleta), prašiči, psi
Not more than 6 ml should be administered at one subcutaneous injection site. 
Pri subkutani aplikaciji lahko na eno mesto vboda apliciramo največ 6 ml.
Residue depletion data were made available and supported a rabbit meat and offal withdrawal period of 6 days following a subcutaneous injection at the recommended dose of 10 mg/kg bw. 
Podatki o izločanju ostankov so bili na voljo in so podpirali 6-dnevno karenco za kunčje meso in organe po subkutanem injiciranju pri priporočenem odmerku 10 mg/kg telesne mase.
Cattle 5 mg of enrofloxacin/kg body weight (bw), corresponding to 1 ml/20 kg bw, once daily for 3-5 days. 
Govedo: 5mg enrofloksacina na kilogram telesne teže, kar ustreza 1 ml/ 20kg t.t dnevno, 3-5 dni.
Treatment of infections of the urinary tract caused by enrofloxacin susceptible strains of Escherichia coli. 
Zdravljenje okužb urinarnega trakta, ki jih povzročajo na enrofloksacin občutljivi sevi Escherichiae coli.
Dogs, cats, cattle, poultry, pigs 
Psi, mačke, teleta, perutnina, prašiči
Treatment of infections of the respiratory tract caused by enrofloxacin susceptible strains of: Pasteurella multocida, Mycoplasma spp., Actinobacillus pleuropneumoniae. 
Prašiči Zdravljenje okužb dihal, ki jih povzročajo na enrofloksacin občutljivi sevi Pasteurellae multocidae,Mycoplasmae spp., in Actinobacillusa pleuropneumoniae.
Avoid skin and eye contact. 
Preprečite stik zdravila za uporabo v veterinarski medicini s kožo in z očmi.
NAME OF THE VETERINARY MEDICINAL PRODUCT <Invented name> 50 mg/ml solution for injection 
IME ZDRAVILA ZA UPORABO V VETERINARSKI MEDICINI <Izmišljeno ime> 50 mg/ml raztopina za injiciranje
2.5 mg of enrofloxacin/kg bw, corresponding to 0.5 ml/10 kg bw, once daily by intramuscular injection for 3 days. 
2,5 mg enrofloksacina na kilogram telesne mase, kar ustreza 0.5 ml/ 10kg t.t, enkrat dnevno, 3 dni, intramuskularno.
Residue depletion data were made available and supported a sheep milk withdrawal period of 3 days following a subcutaneous injection at the recommended dose of 5 mg/kg bw. 
Podatki o izločanju ostankov so bili na voljo in so podpirali 3-dnevno karenco za ovčje mleko po subkutanem injiciranju pri priporočenem odmerku 5 mg/kg telesne mase.
Pigs, cattle, dogs, cats 
Prašiči, govedo, psi, mačke
Treatment of septicaemia caused by enrofloxacin susceptible strains of Escherichia coli. 
Zdravljenje septikemij, ki jih povzročajo na enrofloksacin občutljivi sevi Escherichiae coli.
Following intravenous injection: Meat and offal: 5 days. 
KARENCA Govedo: meso in organi iv. 5 dni sc. 10 dni
Residue depletion data were made available and supported a cattle milk withdrawal period of 4 days following a subcutaneous injection at the recommended dose of 5 mg/kg bw. 
Podatki o izločanju ostankov so bili na voljo in so podpirali 4-dnevno karenco za kravje mleko po subkutanem injiciranju pri priporočenem odmerku 5 mg/kg telesne mase.